6+ day, 22+ hour ago   (191+ words) Long before a patient ever shows a tremor, Parkinson’s disease may already be rewriting the biology of their brain. That gap, between when the disease actually starts and when doctors can currently detect it, is one of the biggest obstacles…...

1+ week, 4+ day ago   (523+ words) longevity.technology AI hunts new uses for Phase 3 metabolic drug Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: THPharm already has…...

1+ week, 6+ day ago   (595+ words) GLP-1 drugs have transformed obesity treatment, but they have also created a new clinical problem: what happens when patients stop taking them. Weight regain after discontinuation is common and well documented, and it has opened a commercial opportunity for therapies…...

2+ week, 34+ min ago   (480+ words) Greenstone Biosciences, a Palo Alto biotech built around a biobank of more than 2,500 donor-derived induced pluripotent stem cell (iPSC) lines, has just received fresh federal backing to test whether skipping the animal step altogether can produce better drugs, faster [1]. The…...

2+ week, 5+ day ago   (418+ words) Researchers have engineered living muscle grafts that spontaneously contract beneath the skin and appear to reproduce some of exercise’s systemic effects, improving measures of muscle function, bone health and metabolism in aging mice [1]. “We have essentially captured the power of…...

2+ week, 5+ day ago   (549+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...